AMBALAL SARABHAI ENTERPRISES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.82 INR | -2.50% |
|
-1.14% | +23.15% |
| Sales 2022 | 1.98B 23.69M | Sales 2023 | 1.72B 20.64M | Capitalization | 1.57B 18.85M |
|---|---|---|---|---|---|
| Net income 2022 | 472M 5.66M | Net income 2023 | 111M 1.33M | EV / Sales 2022 | 1.36 x |
| Net Debt 2022 | 12.84M 154K | Net Debt 2023 | 167M 2.01M | EV / Sales 2023 | 1.01 x |
| P/E ratio 2022 |
5.67
x | P/E ratio 2023 |
14.2
x | Employees | 547 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.50% | ||
| 1 week | -1.14% | ||
| Current month | +2.95% | ||
| 1 month | +1.54% | ||
| 3 months | -11.68% | ||
| 6 months | +19.96% | ||
| Current year | +23.15% |
1 week
46.49
49.50
1 month
42.3856.50
Current year
40.0170.00
1 year
20.9070.00
3 years
20.0470.00
5 years
9.0570.00
10 years
2.3670.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 19-03-31 | |
| Compliance Officer | 30 | 23-10-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 92-07-29 | |
| Director/Board Member | 65 | 78-12-31 | |
| Director/Board Member | 62 | 20-08-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 46.82 | -2.50% | 84,199 |
| 24-04-25 | 48.02 | +1.07% | 56,120 |
| 24-04-24 | 47.51 | +1.78% | 103,736 |
| 24-04-23 | 46.68 | -1.33% | 74,875 |
| 24-04-22 | 47.31 | -0.11% | 99,088 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:00 am EDT
More quotes
Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited, is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +23.15% | 43.02M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- AMBALALSA6 Stock
